RecruitingNot ApplicableNCT07139301

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation：a Randomised Controlled Trial

Sponsor

Capital Medical University

Enrollment

438 participants

Start Date

Sep 4, 2025

Study Type

INTERVENTIONAL

Conditions

Atrial Fibrillation Ischemic Stroke

Summary

This study evaluates the safety and efficacy of early versus delayed initiation of direct oral anticoagulants (DOACs) in patients with acute ischemic stroke related to atrial fibrillation after emergency endovascular therapy (EVT).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at the best time to start blood thinners (anticoagulation) after someone has had an emergency procedure to remove a blood clot in the brain (endovascular thrombectomy) and also has atrial fibrillation (an irregular heart rhythm that increases stroke risk). Starting blood thinners too early or too late can both be dangerous after a stroke. **You may be eligible if...** - You are 18 or older - You had an acute ischemic stroke caused by a blocked large blood vessel - You received emergency clot-removal treatment (endovascular therapy) within 24 hours of stroke onset - You have atrial fibrillation (confirmed by ECG or medical records) - Your brain scan shows no major bleeding or only a minor type of bleeding after treatment **You may NOT be eligible if...** - You have significant or large bleeding in the brain after treatment - You have other reasons you cannot safely take blood thinners - You are under 18 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEarly anticoagulation

Early initiation of direct oral anticoagulants will be started within four days after symptom onset.

DRUGDelayed anticoagulation

Delayed initiation of direct oral anticoagulants will be started between 5-14 days after symptom onset.

Locations(40)

Ma'anshan People's Hospital

Ma’anshan, Anhui, China

Aviation General Hospital

Beijing, Beijing Municipality, China

Beijing Shijingshan Hospital

Beijing, Beijing Municipality, China

Zhangzhou Municipal Hospital of Fujian Province

Zhangzhou, Fujian, China

Heyuan People's Hospital

Heyuan, Guangdong, China

Qinzhou First People's Hospital

Qinzhou, Guangxi, China

Baoding Sixth Hospital

Baoding, Hebei, China

The First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

The Hongda Hospital of Jiamusi University

Jiamusi, Heilongjiang, China

Fangcheng County People's Hospital

Nanyang, Henan, China

Nanyang Central Hospital

Nanyang, Henan, China

Lushan County People's Hospital

Pingdingshan, Henan, China

Xinyang Central Hospital

Xinyang, Henan, China

Queshan County People's Hospital

Zhumadian, Henan, China

Tianyou Hospital, Wuhan University of Science and Technology

Wuhan, Hubei, China

The First Affiliated Hospital of Suzhou University

Suzhou, Jiangsu, China

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, China

Yingkou Central Hospital

Yingkou, Liaoning, China

Ordos Central Hospital

Ordos, Neimenggu, China

Feicheng Hospital Of Shandong Yiyang Health Group

Feicheng, Shandong, China

Jinan Zhangqiu District People's Hospital

Jinan, Shandong, China

Laizhou City People's Hospital

Laizhou, Shandong, China

Liaocheng Neurological Hospital

Liaocheng, Shandong, China

Linyi People's Hospital

Linyi, Shandong, China

Linshu County People's Hospital

Xiazhuang, Shandong, China

Yantai Yeda Hospital

Yantai, Shandong, China

Guoyao Northern Hospital (Baotou)

Baotou, Shanxi, China

ShanXi Cardiovascular Hospital

Taiyuan, Shanxi, China

The Second Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

The People's Hospital of Yueqing

Yueqing, Zhejiang, China

Xuanwu Hospital, Beijing, Beijing 100053

Beijing, China

Guoluo Prefecture People's Hospital

Guoluo, China

Huanghua Municipal People's Hospital

Huanghua, China

First Affiliated Hospital of Henan Polytechnic University

Jiaozuo, China

Qilu Hospital of Shandong University

Jinan, China

Ningjin County People's Hospital

Ningjin, China

Ren Shou County People's Hospital

Renshou, China

Daliuta Experimental District People's Hospital of Shenmu City

Shenmu, China

Xiuyan Central Hospital

Xiuyan, China

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07139301

Related Trials

Feasibility Study of the FARAFLEX Mapping and PFA System

NCT065105564 locations

Continuous Dual Aspiration Technique With Zoom System for Stroke

NCT074919529 locations

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

NCT055575262 locations

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

NCT0597668528 locations

REGistry of Long-term AnTithrombotic TherApy-2

NCT043471871 location